Acelity L.P. Inc. Announces New Senior Leadership Appointments
Company promotes two industry veterans into newly-created Operations and Global Commercial roles
April 17, 2019 16:55 KST
SAN ANTONIO--(Business Wire / Korea Newswire) April 17, 2019 -- Acelity today announced Gaurav Agarwal, Chief Commercial Officer, has been promoted to the position of President and Chief Operating Officer. Additionally, Rohit Kashyap, President of the Americas, has been promoted to the position of President, Global Commercial, responsible for sales development, customer support and business growth in markets around the world.
Agarwal has nearly 20 years of global business management experience in the healthcare industry. Prior to joining the Company in 2014, he served as President, Orthopedic Reconstruction for the Advanced Surgical Devices Division at Smith & Nephew. In his new role as Chief Operating Officer, Agarwal leads KCI’s Product Research and Innovation functions, Manufacturing & Operations, Information Technology, Business Transformation and Quality & Regulatory Affairs. His previous roles include Chief Operating Officer and Senior Vice President for the Advanced Surgical Devices Division at Smith & Nephew, and various leadership positions within GE Healthcare.
“During the last few years, we have been intensely focused on transforming our approach to better equip KCI to deliver new innovations that will evolve the healing process,” said R. Andrew Eckert, President and Chief Executive Officer, Acelity. “Gaurav is instrumental in challenging our organization to do more on behalf of those patients in need of new solutions to change how wounds are healed. In his new role, we look to Gaurav’s leadership to foster closer links between the operational and innovation components of the business to further support product development and portfolio expansion.”
Rohit Kashyap joined KCI more than 20 years ago and since that time has served in numerous leadership roles across the business, most recently as President of the Americas. His previous roles include President of North America, Senior Vice President, Strategy and Business Development, and other leadership roles in strategic marketing and international commercial teams.
Eckert added, “Rohit’s contributions are woven into the DNA of KCI and his leadership and passion for this business over the last 20 years has been a driving force in shaping KCI into the wound care and surgery leader we are today. His competitive spirit and unrelenting focus on the customer will set the pace for our plans for continued expansion in markets around the world. In his new role, he will lead us in strengthening our partnerships with clinicians as together we reimagine the science behind the healing process.”
Acelity L.P. Inc. is a global medical technology company focused on advanced wound care and specialty surgical applications marketed under the KCI brand. The KCI product portfolio is available in more than 90 countries and delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Committed to advancing the science of healing, KCI focuses on innovation. Headquartered in San Antonio, Texas, Acelity employs nearly 5,000 people around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190416005371/en/
- Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion
- KCI Files Registration Statement for Proposed Initial Public Offering
- KCI Launches ABTHERA™ Therapy in Japan
- Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare
- Acelity Appoints Gaurav S. Agarwal as Group President, Businesses and Innovation